Jump to content

Welcome to the new Traders Laboratory! Please bear with us as we finish the migration over the next few days. If you find any issues, want to leave feedback, get in touch with us, or offer suggestions please post to the Support forum here.

  • Welcome Guests

    Welcome. You are currently viewing the forum as a guest which does not give you access to all the great features at Traders Laboratory such as interacting with members, access to all forums, downloading attachments, and eligibility to win free giveaways. Registration is fast, simple and absolutely free. Create a FREE Traders Laboratory account here.

johnnycakes78704

Isis

By johnnycakes78704, in Stocks

Recommended Posts

johnnycakes78704    10

johnnycakes78704
Posted

ISIS Pharmaceuticals just signed a deal which is expected to skyrocket.

 

Genzyme and Isis inked a deal where Genzyme would buy $5M shares at $30 a share, and Genzyme will pay Isis $350M in licensing fees. Isis will also receive up to $750M in commercial milestone payments and $825M in development.

 

As per the deal, the profit will split 70/30 for Genzyme/Isis until the $2B mark is met and then each company will get 50% of the profits.

 

The drug is called Mipomersen and it is a cholesterol reduction drug.

 

This is expected to

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
Go To Topic Listing
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.

  I accept